Related Experiment Video
Updated: Sep 4, 2026

Protocols for Robust Herbicide Resistance Testing in Different Weed Species
Published on: July 2, 2015
Comprehensive analysis of microtubule-inhibiting herbicides reveals shared subcellular phenotypes and distinct
Katharina Kaprocki1, Jennifer Blau1, Michael Betz2
1BASF Agricultural Solutions Deutschland GmbH, Limburgerhof, Germany.
Background:
Herbicides that disrupt microtubules have historically been classified by the Herbicide Resistance Action Committee (HRAC) into microtubule assembly inhibitors (Group 3) and microtubule organization inhibitors (Group 23); however, this classification may not fully reflect their underlying modes of action.
Results:
Using a unified approach combining subcellular phenotyping in Nicotiana tabacum cv. Bright Yellow 2 (BY-2) cells and resistance profiling in Eleusine indica and Chlamydomonas reinhardtii, we show that all tested herbicides produce indistinguishable, dose-dependent subcellular effects, including microtubule depolymerization, multipolar spindle formation, mitotic arrest, and multinucleation. At the resistance level, the α-tubulin T239I mutation confers strong resistance to all microtubule-inhibiting herbicides except the carbamates and propyzamide, whereas several β-tubulin mutations confer resistance to propyzamide.
Conclusion:
These findings reveal distinct sites of action across chemical classes and demonstrate that resistance profiles - rather than subcellular phenotypes - provide a more robust basis for classification. Our results support redefining Group 3 as α-tubulin binders and relocating propyzamide to Group 23, now described as microtubule-interference herbicides with an unresolved site of action, strengthening the mechanistic foundation for improved classification and resistance-management strategies. © 2026 BASF Agricultural Solutions Deutschland GmbH. Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Treatment Resistant Cancers
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Anthelminthic Agents

